US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist

246.750
+9.650+4.07%

Close Feb 28 16:00 ET

246.750
0.0000.00%

Post 20:01 ET

31.94BMarket Cap-113.19P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alnylam Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	580.62M	593.17M	+12.55M
Beat Est.	+32.04%	+34.90%	+2.16%
EPS	-0.59	-0.65	-0.06
Miss Est.	+46.40%	+40.91%	-10.24%

Analyst Rating

Strong Buy

Mar 1, 2025

Alnylam Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 635.087M	--
--	2025/Q1	-- / 587.580M	--
Feb 13, 2025	2024/Q4	593.166M / 580.617M	--
Oct 31, 2024	2024/Q3	500.919M / 527.024M	--
Aug 1, 2024	2024/Q2	659.825M / 444.155M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 635.087M--

--2025/Q1-- / 587.580M--

Feb 13, 20252024/Q4593.166M / 580.617M--

Oct 31, 20242024/Q3500.919M / 527.024M--

Aug 1, 20242024/Q2659.825M / 444.155M--

Unlock Free Earnings Estimates

Open Account

Alnylam Pharmaceuticals Earnings Reports

Alnylam Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 13 08:34 ET

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress

Feb 13 08:14 ET

Alnylam Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 08:25 ET

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

Oct 31, 2024 08:16 ET